Clinical Trial Update: A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab [Phase 3]

View source ↗

Summary

Phase 3 imaging study update using high-resolution peripheral quantitative computed tomography in postmenopausal women previously treated with denosumab; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Low Bone Mass, Low Bone Mineral Density | Phase 3 | Status: COMPLETED | Results posted: 2011-07-28